F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to provide pharmaceutical services including
procedures to ensure the accurate acquiring, receiving, dispensing, administering of all drugs and
biologicals for one (West unit 2) of two treatment carts reviewed for pharmacy services.
The facility failed to ensure timely identification and removal of discontinued medications from a facility
active treatment cart.
This failure could place residents at risk for medication diversion and or accidental medication exposure.
The findings were:
Review of Resident #1's face sheet dated 04/18/23 revealed an [AGE] year-old male admitted to the facility
11/25/22 with diagnoses intrinsic eczema (an overactive immune system that causes the skin to become
dry, inflamed and damaged), congestive heart failure, and diabetes. Review of Resident #1's face sheet
revealed he discharged from the facility 12/21/22 to his home.
Review of Resident #1's physician orders revealed the medication Silver Sulfadiazine Cream 1% prescribed
related to his intrinsic eczema. Review of Resident #1's physician orders revealed the Silver Sulfadiazine
Cream 1% was discontinued 12/21/22 noted Resident #1 was discharged .
Review of Resident #2's face sheet dated 04/18/23 revealed a [AGE] year-old male admitted to the facility
12/12/22 with diagnoses diabetes, heart disease, and acquired absence of right toes. Resident #2
discharged from the facility 12/27/22 to the hospital.
Review of Resident #2's physician orders revealed the medication Metronidazole 1% was ordered for
wound treatment. Review of Resident #2's physician orders revealed the medication Metronidazole 1% was
discontinued 12/27/22 noted resident discharged to the hospital.
An observation on 04/18/23 at 9:02 AM of the [NAME] unit 2 hallway treatment cart revealed an unattended
by staff treatment cart unlocked. The treatment cart and all 4 drawers were capable of being opened.
Contained within the top drawer of the treatment cart were medicated ointments for Resident #1 two tubes
of Silver Sulfadiazine 1% (an antibiotic medication used to treat wound infection) and Resident #2 one tube
of Metronidazole 1% (a medicated gel used to treat inflammatory pimples or red bumps).
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
676395
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676395
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/18/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Healthcare Resort of Plano
3325 West Plano Parkway
Plano, TX 75075
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
An interview on 04/18/23 at 11:56 AM with the DON revealed LVN B was responsible for auditing the
treatment carts weekly for discontinued resident medications, which are promptly removed from active
treatment carts upon a resident's discharge from the facility. The DON stated it was important to remove
discharged resident medications to prevent inadvertent medication administration to a resident and
potential medication errors.
Residents Affected - Few
In a telephone interview on 04/18/23 at 12:32 PM with LVN B revealed she had been the treatment nurse
for two months. LVN B stated the [NAME] unit 2 treatment cart was kept stocked for treatments for each
nurse in the facility to have access to and provide treatments when she was not in the facility. LVN B stated
she was responsible for auditing the [NAME] unit 2 treatment cart weekly for medications that should be
removed. LVN B stated the last time she audited the [NAME] unit 2 treatment cart was two weeks ago from
04/18/23. LVN B stated the medications for discharged residents if not being sent with the resident upon
discharge should be removed from the active treatment cart. LVN B stated the risk of discontinued
discharged resident medications being stored on an active treatment cart was the medication could be
used on another resident leading to a medication error. LVN B stated the last time she audited the [NAME]
unit 2 treatment cart two weeks ago she had not noticed Resident #1 or Resident #2's medicated ointments
in the cart.
Review of facility policy revised 11/13/18, titled; Disposal of Medications, Syringes, and Needles revealed,
.3. Discontinued Medications. Policy: When medications are discontinued by physician order, a resident is
transferred or discharged and does not take medications with him/her, or in the event of resident's death,
the medications are marked as discontinued and destroyed. Procedures: a. Medications awaiting disposal
are stored in a locked secure area designated for that purpose until destroyed. Medications are removed
from the medication cart upon receipt of an order to discontinue (to avoid inadvertent administration).
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676395
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676395
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/18/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Healthcare Resort of Plano
3325 West Plano Parkway
Plano, TX 75075
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to store all drugs and biologicals in
locked compartments under proper temperature controls and permit only authorized personnel to have
access to the keys for one (West unit 2) of two facility treatment carts reviewed.
The facility failed to ensure the [NAME] unit 2 treatment cart was locked when unattended.
This failure could place residents at risk of having access to unauthorized medications and/or lead to
possible harm or drug diversions.
Findings included:
An observation on 04/18/23 at 9:02 AM of the west unit 2 hallway treatment cart revealed an unattended by
staff treatment cart unlocked. The treatment cart and all 4 drawers were capable of being opened.
Contained within the top drawer of the treatment cart were medicated ointments for Resident #1 two tubes
of Silver Sulfadiazine 1% (an antibiotic medication used to treat wound infection) and Resident #2 one tube
of Metronidazole 1% (a medicated gel used to treat inflammatory pimples or red bumps). Observed in the
remaining three drawers were various wound care supplies to include wound dressings, normal saline, and
absorbent wound dressings/coverings.
In an interview on 04/18/23 at 9:15 AM with LVN A revealed she was the unit charge nurse for the west unit
2 hallway. LVN A stated she observed the west unit 2 treatment cart unsecured with all four of its drawers
opened. LVN A stated she observed medicated ointments in the treatment cart for Resident #1 and
Resident #2. LVN A stated the treatment cart should be always locked because residents and or family
members passing by could have access to its contents. LVN A stated the risk of an unsecured treatment
cart would be residents and or family members could gain access to its contents and take items to use on a
resident. LVN A stated as a charge nurse on the west unit 2 hallway she was responsible to supervise the
treatment carts on the unit to ensure each was locked. LVN A stated she had not noticed the treatment cart
unlocked.
An interview on 04/18/23 at 11:56 AM with the DON revealed LVN A the unit charge nurse was responsible
to ensure treatment carts were locked. The DON stated treatment carts should be locked to prevent anyone
passing the cart from having access to the medications and prevent potential medication errors from
occurring.
In a telephone interview on 04/18/23 at 12:32 PM with LVN B revealed she had been the treatment nurse
for 2 months. She stated treatment carts in the facility should be locked when not in use to prevent resident
access to its contents. LVN B stated the west unit 2 treatment cart is kept stocked for treatments for each
nurse in the facility to have access to provide treatments when she was not in the facility.
Review of facility policy revised November 2022, titled; Policy/Procedure-Nursing Clinical revealed, Policy: It
is the policy of this facility to store all drugs and biological in locked compartments under proper
temperature controls. The medication supply is accessible only to licensed nursing personnel, pharmacy
personnel, or staff members lawfully authorized to administer medications .2. Only licensed nurses, the
consultant pharmacist and those lawfully authorized to administer medications
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676395
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676395
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/18/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Healthcare Resort of Plano
3325 West Plano Parkway
Plano, TX 75075
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
(e.g., medication aides) are allowed access to medications. Medication rooms, carts, and medication
supplies are locked or attended by persons with authorized access.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676395
If continuation sheet
Page 4 of 4